Goal 2: Reduce Human Disease

Open up NCATS

The NCATS program for drug repurposing is currently only open to drugs submitted by industry (read, big Pharma). We have had the experience of working to repurpose a generic drug not on their list, and despite great Preliminary data, we could not. This program is a great idea, but needs to be opened to any company and any drug for which solid data backing efficacy and market can be applied. Why do we only want to enhance repurposing of drugs FOR big Pharma?

Tags (Keywords associated with the idea)

Voting

-5 net votes
5 up votes
10 down votes
Active
Idea No. 535